The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMitchells & Butlers Regulatory News (MAB)

Share Price Information for Mitchells & Butlers (MAB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 246.50
Bid: 246.00
Ask: 247.00
Change: 4.00 (1.65%)
Spread: 1.00 (0.407%)
Open: 239.00
High: 247.50
Low: 239.00
Prev. Close: 242.50
MAB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Admission of New Shares

12 Mar 2021 07:00

RNS Number : 0272S
Mitchells & Butlers PLC
12 March 2021
 

 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM AUSTRALIA, CANADA, THE REPUBLIC OF IRELAND, JAPAN, NEW ZEALAND, SOUTH AFRICA, THE UNITED STATES OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

 

NEITHER THIS ANNOUNCEMENT NOR ANYTHING CONTAINED HEREIN SHALL FORM THE BASIS OF, OR BE RELIED UPON IN CONNECTION WITH, ANY OFFER OR COMMITMENT WHATSOEVER IN ANY JURISDICTION. ANY DECISION TO PURCHASE, SUBSCRIBE FOR, OTHERWISE ACQUIRE, SELL OR OTHERWISE DISPOSE OF, ANY SECURITIES REFERRED TO IN THIS ANNOUNCEMENT MUST BE MADE SOLELY ON THE BASIS OF THE INFORMATION THAT IS CONTAINED IN AND INCORPORATED BY REFERENCE INTO THE PROSPECTUS. COPIES OF THE PROSPECTUS ARE AVAILABLE AT WWW.MBPLC.COM/INVESTORS/CAPITALRAISE.COM

 

 

12 March 2021

Mitchells & Butlers plc

LEI no: 213800JHYNDNB1NS2W10

 

Admission of New Shares

 

Mitchells & Butlers plc (the "Company") today announces that, pursuant to the Open Offer announced on 22 February 2021, 166,911,444 New Shares will be admitted to listing on the premium listing segment of the Official List of the Financial Conduct Authority and will be admitted to trading on London Stock Exchange plc's Main Market for listed securities at 8.00 a.m. today.

 

Capitalised terms not otherwise defined in this announcement shall have the meaning set out in the combined prospectus and circular published by the Company on 22 February 2021 (the "Prospectus").

 

In conformity with Rule 5.6.1 of the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority, the Company hereby notifies the market that as at 12 March 2021 the Company's issued share capital consists of 596,192,913 ordinary shares of 8 13/24 pence each. The Company does not hold any shares in treasury.

 

The total number of voting rights in the Company as at 12 March 2021 is therefore 596,192,913. This figure may be used by shareholders as the denominator for the calculations by which they determine if they are required to notify their interest in, or a change in their interest in, the Company under the Disclosure Guidance and Transparency Rules.

 

Contact details:

 

Company

Mitchells & Butlers plc

Tim Jones, Chief Financial Officer

Tel: +44 (0) 121 498 6112

Gabby Shilvock, Investor Relations

Tel: +44 (0)121 498 6514

 

Financial Adviser, Global Co-ordinator, Joint Bookrunner, Corporate Broker and Sponsor Morgan Stanley

Nick Bishop

Andrew Foster

Melissa Godoy

Anthony Zammit

Tel: +44 (0) 20 7425 8000

 

Financial Adviser

Rothschild & Co

Edward Duckett

Francis Burkitt

Claire Suddens-Spiers

Shannon Nicholls

Tel: +44 (0) 20 7280 5000

 

Joint Bookrunner

HSBC

Richard Fagan

Pushpjit Singh Malik

Tel: +44 (0) 20 7991 8888

 

Joint Bookrunner

Santander

Javier Mata

Simon Payne

Michael Ward

Santander Equity Syndicate

Tel: +34 692 206 356

 

Media

Finsbury

James Murgatroyd

Tel: +44 (0) 20 7251 3801

 

IMPORTANT NOTICES

 

This announcement has been issued by and is the sole responsibility of the Company. No representation or warranty, express or implied, is or will be made as to, or in relation to, and no responsibility or liability is or will be accepted by any of the Underwriters or the Financial Adviser or by any of their respective affiliates or agents or any of their respective directors, officers, employees, members, agents, advisers, representatives or shareholders as to, or in relation to, the accuracy or completeness of this announcement or any other written or oral information made available to any interested party or its advisers, and any liability therefore is expressly disclaimed.

 

Each of Morgan Stanley and HSBC are authorised and regulated in the United Kingdom by the FCA and the Prudential Regulation Authority ("PRA") and the Financial Adviser is authorised and regulated in the United Kingdom by the FCA. Santander is authorised and regulated by the Bank of Spain and subject to supervision by the Bank of Spain and the European Central Bank and to limited regulation by the FCA and PRA. None of the Underwriters or the Financial Adviser will regard any person (whether or not a recipient of this announcement) other than the Company as its customer in relation to the Open Offer and none of them will be responsible for providing the protections afforded to its customers to any other person or for providing advice to any other person in relation to the Open Offer.

 

The distribution of this announcement into jurisdictions other than the United Kingdom may be restricted by law, and, therefore, persons into whose possession this announcement comes should inform themselves about and observe any such restrictions. Any failure to comply with any such restrictions may constitute a violation of the securities laws of such jurisdiction. In particular, subject to certain exceptions, this announcement, the Prospectus and the Application Forms should not be distributed, forwarded to or transmitted in or into the United States or any other Excluded Territory.

 

The New Shares, Open Offer Entitlements and Excess Open Offer Entitlements have not been and will not be registered under the US Securities Act of 1933, or under any securities laws of any state or other jurisdiction of the United States, and may not be offered, sold, taken up, exercised, resold, transferred or delivered, directly or indirectly, within the United States. There will be no public offer of the New Shares, Open Offer Entitlements and Excess Open Offer Entitlements in the United States. This announcement and any other document relating to the Open Offer may not be sent into, distributed or otherwise disseminated (including by custodians, nominees or trustees or others that may have a contractual or legal obligation to forward such documents) in the United States by use of the mails or by any means or instrumentality of interstate or foreign commerce (including, without limitation, email, facsimile transmission, the internet or other form of electronic transmission) or any facility of a national securities exchange of the United States.

 

The New Shares to be issued Open Offer will not be admitted to trading on any stock exchange other than the London Stock Exchange.

 

Neither the content of the Company's website nor any website accessible by hyperlinks on the Company's website is incorporated in, or forms part of, this announcement.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ALSDKDBQCBKDDND
Date   Source Headline
30th Apr 202411:00 amRNSTotal Voting Rights
29th Apr 20243:08 pmRNSDirector/PDMR Shareholding
2nd Apr 20243:45 pmRNSDirector/PDMR Shareholding
2nd Apr 20241:30 pmRNSBlock listing Interim Review
28th Mar 20241:00 pmRNSTotal Voting Rights
4th Mar 202412:30 pmRNSDirector/PDMR Shareholding
29th Feb 20242:00 pmRNSTotal Voting Rights
5th Feb 20243:30 pmRNSDirector/PDMR Shareholding
31st Jan 20242:21 pmRNSDirector/PDMR Shareholding
31st Jan 202410:00 amRNSTotal Voting Rights
23rd Jan 202412:16 pmRNSResult of Annual General Meeting
17th Jan 20247:00 amRNSFirst Quarter Trading Update
15th Jan 20241:00 pmRNSNotice of First Quarter Trading Update
8th Jan 20242:00 pmRNSDirector/PDMR Shareholding
2nd Jan 20242:00 pmRNSTotal Voting Rights
22nd Dec 20239:36 amRNSDirectorate Declaration
20th Dec 202312:00 pmRNSAnnual Report 2023
14th Dec 20232:30 pmRNSDirector/PDMR Shareholding
11th Dec 20234:35 pmRNSDirector/PDMR Shareholding
8th Dec 202311:30 amRNSDirector/PDMR Shareholding
7th Dec 202310:30 amRNSDirector/PDMR Shareholding
30th Nov 202311:30 amRNSTotal Voting Rights
30th Nov 20237:00 amRNSFULL YEAR RESULTS
24th Nov 202312:00 pmRNSNotice of Final Results
14th Nov 202310:45 amRNSDirector/PDMR Shareholding
13th Nov 20232:30 pmRNSDirector/PDMR Shareholding
31st Oct 20231:00 pmRNSTotal Voting Rights
31st Oct 202310:00 amRNSDirectorate Declaration
16th Oct 20232:00 pmRNSDirector/PDMR Shareholding
9th Oct 20233:46 pmRNSListing Application
2nd Oct 20232:30 pmRNSBlock listing Interim Review
28th Sep 20237:00 amRNSFourth Quarter Trading Update
25th Sep 202312:00 pmRNSNotice of Fourth Quarter Trading Statement
18th Sep 20233:00 pmRNSDirector/PDMR Shareholding
15th Sep 20232:20 pmRNSDirector/PDMR Shareholding
15th Sep 20232:15 pmRNSDirector/PDMR Shareholding
31st Aug 20232:32 pmRNSTotal Voting Rights
21st Aug 20232:30 pmRNSDirector/PDMR Shareholding
31st Jul 20231:14 pmRNSTotal Voting Rights
27th Jul 20237:00 amRNSThird Quarter Trading Update
24th Jul 20232:50 pmRNSDirector/PDMR Shareholding
21st Jul 202312:06 pmRNSNotice of Third Quarter Trading Update
30th Jun 202310:30 amRNSTotal Voting Rights
26th Jun 202311:15 amRNSDirector/PDMR Shareholding
31st May 20233:15 pmRNSTotal Voting Rights
30th May 20233:00 pmRNSDirector/PDMR Shareholding
17th May 20237:00 amRNSHalf Year Results
11th May 20233:30 pmRNSNotice of Half Year Results
2nd May 20231:52 pmRNSDirector/PDMR Shareholding
28th Apr 202310:50 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.